AGRIFORCE GROWING SYSTEMS LT (AGRI)       1.23  0 (0%)

1.23  0 (0%)

CAC009481069 - Common Stock - After market: 1.23 0 (0%)


Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to AGRI. AGRI was compared to 105 industry peers in the Food Products industry. Both the profitability and financial health of AGRI have multiple concerns. AGRI is valued expensive and it does not seem to be growing.

Note: AGRI has only limited data available, so a full analysis was not possible, which makes the total rating unfair.




Profitability

Profitability Rating

1

The Piotroski-F score of AGRI is 3.00. This is a low score and indicates issues in the health and profitability of AGRI.

VS Industry

Valuation

Valuation Rating

1

With a price book ratio of 1.95, AGRI is valued correctly.
Compared to an average industry price book ratio of 1.87, AGRI is valued in line with its industry peers.

AGRI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AGRI. No positive earnings are expected for the next year.
VS Industry

Price/Book (1.95) VS Industry: 47% outperformed.

272.78
0.03

Growth

Growth Rating

2

Based on estimates for the next 5 years, AGRI will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.87% on average per year.

The earnings per share for AGRI have decreased strongly by -93.41% in the last year.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A N/A -93.41% 25.92% -2.06% 25.83% 14.87%
RevenueN/A N/A N/A N/A N/A N/A N/A

Health

Health Rating

3

When comparing the Quick Ratio to an average industry Quick Ratio of 0.90, AGRI is better placed than the average industry peer to meet its short term obligations.
The Debt to Equity ratio of AGRI is way better than the industry averages. AGRI has a better rating than 86% of its industry peers.
AGRI has a Current Ratio of 1.37. This is a normal value and indicates that AGRI is financially healthy and should not expect problems in meeting its short term obligations.
AGRI has a Quick Ratio of 1.37. This is a normal value and indicates that AGRI is financially healthy and should not expect problems in meeting its short term obligations.

Compared to an average industry Current Ratio of 1.80, AGRI is worse placed to pay its short term obligations than its industry peers.
Based on the Altman-Z score of -2.68, we must say that AGRI is in the distress zone and has some risk of bankruptcy.
Compared to an average industry Altman-Z score of 2.21, AGRI is in worse financial state than most of its industry peers. 88% of its industry peers have a better Altman-Z score.
AGRI has a quite weak Piotroski-F score of 3.00. This indicates issues in the health and profitability of AGRI.
VS Industry

Debt/Equity (0) VS Industry: 86% outperformed.

53.34
0.00

Quick Ratio (1.37) VS Industry: 72% outperformed.

0.01
48.00

Current Ratio (1.37) VS Industry: 33% outperformed.

0.01
49.63

Altman-Z (-2.68) VS Industry: 12% outperformed.

-34.87
80.57

Dividend

Dividend Rating

0

AGRI does not give a dividend.

AGRIFORCE GROWING SYSTEMS LT1.23

NASDAQ:AGRI (2/7/2023, 7:23:02 PM)0 (0%)

After market: 1.23 0 (0%)

Chartmill FA Rating
GICS Sector Consumer Staples
GICS IndustryGroup Food, Beverage & Tobacco
GICS Industry Food Products
Earnings (Last) 11-10 2022-11-10/amc Earnings (Next) N/A N/A
Inst Owners 1.61% Inst Owner Change -2.19%
Ins Owners 6.51% Ins Owner Change 0%
Market Cap 19.33M Analysts 82.5
Price Target 5.27 (328.46%)

Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y) N/A DP N/A
Div Incr Years N/A Div Non Decr Years N/A
Ex-Date N/A

Surprises & Revisions
EPS beat(2) N/A Avg EPS beat(2) -22.28%
Min EPS beat(2) -23.46% Max EPS beat(2) -21.11%
EPS beat(4) N/A Avg EPS beat(4) -19.36%
Min EPS beat(4) -23.46% Max EPS beat(4) -13.52%
Revenue beat(2) N/A Avg Revenue beat(2) N/A
Min Revenue beat(2) N/A Max Revenue beat(2) N/A
Revenue beat(4) N/A Avg Revenue beat(4) N/A
Min Revenue beat(4) N/A Max Revenue beat(4) N/A
PT rev (1m) 0% PT rev (3m) 0%
EPS NQ rev (1m) 0% EPS NQ rev (3m) -91.11%
EPS NY rev (1m) 0% EPS NY rev (3m) -21.01%
Revenue NQ rev (1m) 0% Revenue NQ rev (3m) -85.49%
Revenue NY rev (1m) 0% Revenue NY rev (3m) -21.82%

Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.95
P/tB 341.54
EV/EBITDA N/A
EPS(TTM) -0.78 EY N/A
EPS(NY) -0.69 Fwd EY N/A
FCF(TTM) -0.74 FCFY N/A
OCF(TTM) -0.7 OCFY N/A
SpS N/A BVpS 0.63
TBVpS 0 PEG (NY) N/A
PEG (5Y) N/A

Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM N/A
GM N/A
ROICexgc(3y) N/A ROICexcg growth 3Y N/A
ROICexcg growth 5Y N/A ROICexc(3y) N/A
ROICexc growth 3Y N/A ROICexc growth 5Y N/A
OM growth 3Y N/A OM growth 5Y N/A
PM growth 3Y N/A PM growth 5Y N/A
GM growth 3Y N/A GM growth 5Y N/A
F-Score 3 Asset Turnover N/A

Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 3270.9%
Profit Quality N/A
Current Ratio 1.37
Quick Ratio 1.37
Altman-Z -2.68
F-Score 3 WACC N/A
ROIC/WACC N/A Cap/Depr(3y) 774.35%
Cap/Depr(5y) N/A Profit Quality(3y) N/A
Profit Quality(5y) N/A

Growth
EPS 1Y -93.41% EPS 3Y N/A
EPS 5Y N/A EPS growth Q2Q -17.89%
EPS Next Y 25.92% EPS Next 2Y -2.06%
EPS Next 3Y 25.83% EPS Next 5Y 14.87%
Revenue growth 1Y N/A Revenue growth 3Y N/A
Revenue growth 5Y N/A Revenue growth Q2Q N/A
Revenue Next Year N/A Revenue Next 2Y N/A
Revenue Next 3Y N/A Revenue Next 5Y N/A
EBIT growth 1Y -184.11% EBIT growth 3Y N/A
EBIT growth 5Y N/A EBIT Next Year -112.38%
EBIT Next 3Y 43.78% EBIT Next 5Y 66.4%
FCF growth 1Y -468.72% FCF growth 3Y N/A
FCF growth 5Y N/A OCF growth 1Y -439.6%
OCF growth 3Y N/A OCF growth 5Y N/A

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA